
Gunderson Dettmer

Panacea Venture

Panacea Venture is a healthcare focused venture capital firm, with offices in Shanghai, Hong Kong, and Silicon Valley Founded in 2017, Panacea Venture focuses on investing in and incubating early-stage life science companies with breakthrough technologies and discoveries that can potentially address unmet medical needs and enhance the quality of life on a global scale We currently manage three USD funds and one RMB fund Our investment team members are located across China, U S , and Europe, with an extensive coverage of all the major global life sciences hubs
The life science industry is fundamentally driven by innovation Therefore, we actively seek for seminal research results, original ideas or invention, and the brightest minds and seasoned entrepreneurs that can help create and develop first-in-class or best-in-class therapeutics, medical devices, and diagnostics We continue to anticipate and adapt to the changes of research, industry and regulatory trends, and remain constantly curious and inquisitive to new discoveries with clinical benefits and commercial potential
With a very hands-on approach to the management of our portfolio companies, our investment strategy is focused and precise Our professionals are often acting as members of the founding team Utilizing our global network, we can bring in significant resources with deep industry experience and expertise to our portfolio companies As a result, these companies are able to fully realize their intrinsic value and potential with multiple value inflection points and sustained competitiveness
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Panacea Venture.
Similar listings buyers compare against this one.

Gunderson Dettmer

Partners Innovation Fund

Coronis Medical Ventures

Northwest Technology Ventures

Trolley Venture Partners

Novartis Bioventures
Everything here links back to the same verified catalogue. Pick your next stop.